Rockwell Medical (RMTI) Net Cash Flow (2010 - 2026)
Rockwell Medical (RMTI) posted Net Cash Flow of -$1.1 million for Q1 2026, up 61.39% on a QoQ basis from -$2.9 million in Q4 2025, and up 73.43% year-over-year from -$654460.0 in Q1 2025.
Rockwell Medical (RMTI) Net Cash Flow (2010 - 2026) Analysis & Trends
Rockwell Medical's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$1.1 million for Q1 2026.
- Quarterly Net Cash Flow rose 73.43% year-over-year to -$1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 139.04% YoY) and the FY2025 annual result came in at -$5.0 million, down 174.69% from the prior year.
- Net Cash Flow was -$1.1 million for Q1 2026 at Rockwell Medical, up from -$2.9 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $20.9 million in Q2 2022 and bottomed at -$17.8 million in Q3 2022.
- A 5-year average of -$219588.2 and a median of -$1.1 million in 2026 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow surged 732.94% — and 2024, when it plunged 394.47%.
- Rockwell Medical's Net Cash Flow stood at -$2.9 million in 2022, then surged by 142.49% to $1.2 million in 2023, then jumped by 171.87% to $3.3 million in 2024, then slumped by 188.42% to -$2.9 million in 2025, then soared by 61.39% to -$1.1 million in 2026.
- Business Quant data shows RMTI's Net Cash Flow at -$1.1 million in Q1 2026, -$2.9 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | -1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.14 Mn |
| Mar 31, 2026 | -1.14 Mn |
| Dec 31, 2025 | -2.94 Mn |
| Dec 31, 2025 | -2.94 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | -4.27 Mn |
| Mar 31, 2025 | -4.27 Mn |
| Dec 31, 2024 | 3.33 Mn |
| Dec 31, 2024 | 3.33 Mn |
| Sep 30, 2024 | 476,000.00 |
| Sep 30, 2024 | 476,000.00 |
| Jun 30, 2024 | 5.22 Mn |
| Jun 30, 2024 | 5.22 Mn |
| Mar 31, 2024 | -2.34 Mn |
| Mar 31, 2024 | -2.34 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Dec 31, 2023 | 1.22 Mn |